The Relationship Among Oxidative and Anti-Oxidative Parameters and Myeloperoxidase in Subjects With Obstructive Sleep Apnea Syndrome

References

1. 1.↵
   1. Young T,
   2. Palta M,
   3. Dempsey J,
   4. Skatrud J,
   5. Weber S,
   6. Badr S

   . The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328(17):1230–1235.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Young T,
   2. Shahar E,
   3. Nieto FJ,
   4. Redline S,
   5. Newman AB,
   6. Gottlieb DJ,
   7. et al

   . Predictors of sleep-disordered breathing in community-dwelling adults: the sleep heart health study. Arch Intern Med 2002;162(8):893–900.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Somers VK,
   2. White DP,
   3. Amin R,
   4. Abraham WT,
   5. Costa F,
   6. Culebras A,
   7. et al

   . Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center On Sleep Disorders Research (National Institutes of health). Circulation 2008;118(10):1080–1110.

   OpenUrlFREE Full Text
4. 4.
   1. Kasai T,
   2. Floras JS,
   3. Bradley TD

   . Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 2012;126(12):1495–1510.

   OpenUrlFREE Full Text
5. 5.↵
   1. Lavie L

   . Sleep apnea syndrome, endothelial dysfunction, and cardiovascular morbidity. Sleep 2004;27(6):1053–2055.

   OpenUrlPubMedWeb of Science
6. 6.↵
   1. Leger D,
   2. Bayon V,
   3. Laaban JP,
   4. Philip P

   . Impact of sleep apnea on economics. Sleep Med Rev 2012;16(5):455–462.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Klebanoff SJ

   . Myeloperoxidase: friend and foe. J Leukoc Biol 2005;77(5):598–625.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Hampton MB,
   2. Kettle AJ,
   3. Winterbourn CC

   . Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998;92(9):3007–3017.

   OpenUrlFREE Full Text
9. 9.↵
   1. Calverley PM,
   2. Anderson JA,
   3. Celli B,
   4. Ferguson GT,
   5. Jenkins C,
   6. Jones PW,
   7. Yates JC,
   8. Vestbo J

   . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356(8):775–789.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Dyugovskaya L,
    2. Lavie P,
    3. Lavie L

    . Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165(7):934–939.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.
    1. Schulz R,
    2. Mahmoudi S,
    3. Hattar K,
    4. Sibelius U,
    5. Olschewski H,
    6. Mayer K,
    7. et al

    . Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000;162(2):566–570.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.
    1. Barceló A,
    2. Miralles C,
    3. Barbé F,
    4. Vila M,
    5. Pons S,
    6. Agustí AG

    . Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 2000;16(4):644–647.

    OpenUrlAbstract
13. 13.
    1. Lavie L,
    2. Vishnevsky A,
    3. Lavie P

    . Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004;27(1):123–128.

    OpenUrlPubMedWeb of Science
14. 14.↵
    1. Yamauchi M,
    2. Nakano H,
    3. Maekawa J,
    4. Okamoto Y,
    5. Ohnishi Y,
    6. Suzuki T,
    7. Kimura H

    . Oxidative stress in obstructive sleep apnea. Chest 2005;127(5):1674–1679.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Wysocka E,
    2. Cofta S,
    3. Cymerys M,
    4. Gozdzik J,
    5. Torlinski L,
    6. Batura-Gabryel H

    . The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients. J Physiol Pharmacol 2008;59(Suppl 6):761–769.

    OpenUrlPubMed
16. 16.
    1. Faure P,
    2. Tamisier R,
    3. Baguet JP,
    4. Favier A,
    5. Halimi S,
    6. Lévy P,
    7. Pépin JL

    . Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur Respir J 2008;31(5):1046–1053.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Christou K,
    2. Moulas AN,
    3. Pastaka C,
    4. Gourgoulianis KI

    . Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 2003;4(3):225–228.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Erel O

    . A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112–119.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Erel O

    . A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38(12):1103–1111.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Demirbag R,
    2. Gur M,
    3. Yilmaz R,
    4. Kunt AS,
    5. Erel O,
    6. Andac MH

    . Influence of oxidative stress on the development of collateral circulation in total coronary occlusions. Int J Cardiol 2007;116(1):14–19.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Harma MI,
    2. Harma M,
    3. Erel O

    . Measuring plasma oxidative stress biomarkers in sport medicine. Eur J Appl Physiol 2006;97(4):505.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Krawisz JE,
    2. Sharon P,
    3. Stenson WF

    . Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster models. Gastroenterology 1984;87(6):1344–1350.

    OpenUrlPubMedWeb of Science
23. 23.↵
    1. Ryan S,
    2. Taylor CT,
    3. McNicholas WT

    . Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112(17):2660–2667.

    OpenUrlAbstract/FREE Full Text
24. 24.
    1. Ryan S,
    2. Taylor CT,
    3. McNicholas WT

    . Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006;174(7):824–830.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Yokoe T,
    2. Minoguchi K,
    3. Matsuo H,
    4. Oda N,
    5. Minoguchi H,
    6. Yoshino G,
    7. et al

    . Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107(8):1129–1134.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Arias MA,
    2. García-Río F,
    3. Alonso-Fernández A,
    4. Hernanz A,
    5. Hidalgo R,
    6. et al

    . CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 2008;32(4):1009–1015.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Akpinar ME,
    2. Yigit O,
    3. Altundag A,
    4. Demirel GY,
    5. Kocak I

    . Salivary and serum myeloperoxidase in obstructive sleep apnea. J Otolaryngol Head Neck Surg 2012;41(3):215–221.

    OpenUrlPubMed
28. 28.↵
    1. Esterbauer H,
    2. Wäg H,
    3. Puhl H

    . Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993;49(3):566–576.

    OpenUrlAbstract/FREE Full Text
29. 29.
    1. Gutiérrez-Salinas J,
    2. García-Ortíz L,
    3. Morales González JA,
    4. Hernández-Rodríguez S,
    5. Ramírez-García S,
    6. Núñez-Ramos NR,
    7. et al

    . In vitro effect of sodium flüoride on malondialdehyde concentration and on superoxide dismutase, catalase, and glutathione peroxidase in human erythrocytes. Scientific World J 2013;864718.
30. 30.
    1. Chen Y,
    2. Dong H,
    3. Thompson DC,
    4. Shertzer HG,
    5. Nebert DW,
    6. Vasiliou V

    . Glutathione defense mechanism in liver injury: insights from animal models. Food Chem Toxicol 2013;60:38–44.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Faienza MF,
    2. Francavilla R,
    3. Goffredo R,
    4. Ventura A,
    5. Marzano F,
    6. Panzarino G,
    7. et al

    . Oxidative stress in obesity and metabolic syndrome in children and adolescents. Horm Res Paediatr 2012;78(3):158–164.

    OpenUrlPubMed
32. 32.↵
    1. Yonezawa K,
    2. Morimoto N,
    3. Matsui K,
    4. Tenjin T,
    5. Yoneda M,
    6. Emoto T,
    7. et al

    . Significance of the neutrophil myeloperoxidase index in patients with atherosclerotic diseases. Kobe J Med Sci 2012;58(5):128–137.

    OpenUrl
33. 33.
    1. Mocatta TJ,
    2. Pilbrow AP,
    3. Cameron VA,
    4. Senthilmohan R,
    5. Frampton CM,
    6. Richards AM,
    7. Winterbourn CC

    . Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007;49(20):1993–2000.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Tang WH,
    2. Wu Y,
    3. Nicholls SJ,
    4. Hazen SL

    . Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease. Clin Chem 2011;57(1):33–39.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Hanikoglu F,
    2. Huseyinoglu N,
    3. Ozben S,
    4. Cort A,
    5. Ozdem S,
    6. Ozben T

    . Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome. Int J Neurosci 2015;125(9):655–662.

    OpenUrlPubMed
36. 36.↵
    1. Wali SO,
    2. Bahammam AS,
    3. Massaeli H,
    4. Pierce GN,
    5. Iliskovic N,
    6. Singal PK,
    7. Kryger MH

    . Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 1998;21(3):290–296.

    OpenUrlPubMedWeb of Science
37. 37.↵
    1. Grabska-Kobylecka I,
    2. Kobylecki A,
    3. Bialasiewicz P,
    4. Krol M,
    5. Ehteshamirad G,
    6. Kasielski M,
    7. et al

    . No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea. J Negat Results BioMed 2008;7:10.

    OpenUrlPubMed